September 15, 2015 – The U.S. Preventive Services Task Force posted today a draft recommendation statement and draft evidence summaries on aspirin to prevent cardiovascular disease and cancer. These are available for review and public comment from September 15, 2015 through October 12, 2015. To review the draft recommendation statement and draft evidence summaries and submit comments, go to /uspstf/public-comments-and-nominations/opportunity-for-public-comment.
